⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11103862 | 0.80 | MEN1 (0.52) | — | |
| SCHEMBL11107953 | 0.80 | MEN1 (0.52) | — | |
| SCHEMBL5487957 | 0.80 | MEN1 (0.52) | — | |
| SCHEMBL4298276 | 0.78 | ALDH1A1 (0.43) | — | |
| Hydrochloric Acid SCHEMBL28371398 | 0.78 | MEN1 (0.50) | — | |
| Benzene SCHEMBL28173940 | 0.76 | MEN1 (0.48) | — | |
| SCHEMBL11700080 | 0.74 | — | — | |
| SCHEMBL183872 | 0.74 | — | — | |
| SCHEMBL17623356 | 0.74 | — | — | |
| SCHEMBL1752174 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107519840-A | Carrying methods and silicon matrix material and application of a kind of ZIFs on silicon matrix | 中国科学院大连化学物理研究所 | 2017-12-29 | — | — | CN | claimed |
| US-4251320-A | Method of producing a mineral fiber product | ROCKWOOL AKTIEBOLAG (SE) | 1981-02-17 | — | — | US | claimed |
| US-20240226114-A1 | INHIBITORS AND USES THEREOF | VIVIDION THERAPEUTICS, INC. | 2024-07-11 | — | — | US | disclosed |
| CN-113493458-B | Preparation method of temozolomide | 鲁南制药集团股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| CN-113493418-B | Temozolomide intermediate compound IV | 鲁南制药集团股份有限公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ABM THERAPEUTICS CORP (US) | 2023-09-28 | — | — | US | disclosed |
| US-20230158177-A1 | HYPOXIA-TARGETING CONTRAST AGENT AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230158177-A1 | HYPOXIA-TARGETING CONTRAST AGENT AND METHODS OF USE THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230071620-A1 | PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS | ACHILLION PHARMACEUTICALS, INC. | 2023-03-09 | — | — | US | disclosed |
| US-20230055237-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF CYSTIC FIBROSIS | FLATLEY DISCOVERY LAB, LLC | 2023-02-23 | — | — | US | disclosed |
| US-11247988-B2 | RAD51 inhibitors | CYTEIR THERAPEUTICS, INC. (US) | 2022-02-15 | — | — | US | disclosed |
| US-20080200689-A1 | 1-Substituted-4-nitroimidazole compound and method for preparing the same | OTSUKA PHARMACEUTICAL CO., LTD. | 2008-08-21 | — | — | US | disclosed |
| US-20080090781-A1 | Formulations Containing Alkylphosphocholines Using Novel Negative Charge Carriers | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2008-04-17 | — | — | US | disclosed |
| EP-1827379-A2 | FORMULATIONS CONTAINING ALKYLPHOSPHOCHOLINES USING NOVEL NEGATIVE CHARGE CARRIERS | MPG Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006042751-A2 | FORMULATIONS CONTAINING ALKYLPHOSPHOCHOLINES USING NOVEL NEGATIVE CHARGE CARRIERS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2006-04-27 | — | — | WO | disclosed |
| US-20030199476-A1 | Medicament for the stimulation of leucopoiesis and treatment of tumour and protozoan diseases acarinosis and arthropod-borne diseases and a method for production thereof | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2003-10-23 | — | — | US | disclosed |
| WO-2003028701-A2 | LIPOSOMES CONTAINING (ETHER)LYSOLECITHINS | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2003-04-10 | — | — | WO | disclosed |
| WO-2003028736-A2 | PHARMACEUTICAL PREPARATIONS COMPRISING ALKYL PHOSPHOCHOLINE COMPOUNDS IN LIPOSOMES WHICH MAY BE STERILE-FILTERED OR HEAT-STERILISED | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2003-04-10 | — | — | WO | disclosed |
| EP-1267943-A2 | MEDICAMENT FOR THE STIMULATION OF LEUCOPOIESIS AND TREATMENT OF TUMOUR AND PROTOZOAN DISEASES ACARINOSIS AND ARTHROPOD-BORNE DISEASES AND A METHOD FOR PRODUCTION THEREOF | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001072289-A2 | MEDICAMENT FOR THE STIMULATION OF LEUCOPOIESIS AND TREATMENT OF TUMOUR AND PROTOZOAN DISEASES ACARINOSIS AND ARTHROPOD-BORNE DISEASES AND A METHOD FOR PRODUCTION THEREOF | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2001-10-04 | — | — | WO | disclosed |